Tumor suppressor protein VHL inhibits Hedgehog-Gli activation through suppression of Gli1 nuclear localization.

Abstract The transcription factor Gli1 acts in the last known step of the Hedgehog signaling, and deregulation of Gli1 is implicated in human cancers. VHL protein is widely expressed in both fetal and adult tissues and acts as a tumor suppressor. Here, we demonstrate the molecular mechanism through which VHL inhibits the Hedgehog–Gli pathway. VHL decreased Gli1-mediated promoter transactivation as well as the expression of Hedgehog/Gli pathway target genes. Nuclear translocation of cytosolic Gli1 protein was inhibited by VHL via protein–protein interaction. These results indicate that overexpression of VHL may antagonize Hedgehog–Gli activation at the post-translational level in Hedgehog pathway-induced cancers. Structured summary of protein interactions VHL-30 physically interacts with GLI1 by anti tag coimmunoprecipitation (View Interaction: 1 , 2 ) GLI1 and VHL colocalize by fluorescence microscopy ( View interaction ) VHL-19 physically interacts with GLI1 by anti tag coimmunoprecipitation (View Interaction: 1 , 2 ) VHL physically interacts with GLI1 by pull down ( View interaction )